164 related articles for article (PubMed ID: 2268581)
1. Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia.
Børresen AL; Andersen TI; Tretli S; Heiberg A; Møller P
Genes Chromosomes Cancer; 1990 Nov; 2(4):339-40. PubMed ID: 2268581
[TBL] [Abstract][Full Text] [Related]
2. Breast and other cancers in families with ataxia-telangiectasia.
Swift M; Reitnauer PJ; Morrell D; Chase CL
N Engl J Med; 1987 May; 316(21):1289-94. PubMed ID: 3574400
[TBL] [Abstract][Full Text] [Related]
3. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries.
Olsen JH; Hahnemann JM; Børresen-Dale AL; Brøndum-Nielsen K; Hammarström L; Kleinerman R; Kääriäinen H; Lönnqvist T; Sankila R; Seersholm N; Tretli S; Yuen J; Boice JD; Tucker M
J Natl Cancer Inst; 2001 Jan; 93(2):121-7. PubMed ID: 11208881
[TBL] [Abstract][Full Text] [Related]
4. Incidence of cancer in 161 families affected by ataxia-telangiectasia.
Swift M; Morrell D; Massey RB; Chase CL
N Engl J Med; 1991 Dec; 325(26):1831-6. PubMed ID: 1961222
[TBL] [Abstract][Full Text] [Related]
5. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain.
Pippard EC; Hall AJ; Barker DJ; Bridges BA
Cancer Res; 1988 May; 48(10):2929-32. PubMed ID: 3359449
[TBL] [Abstract][Full Text] [Related]
6. Cancers in 44 families with ataxia-telangiectasia.
Morrell D; Chase CL; Swift M
Cancer Genet Cytogenet; 1990 Nov; 50(1):119-23. PubMed ID: 2253179
[TBL] [Abstract][Full Text] [Related]
7. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia.
Inskip HM; Kinlen LJ; Taylor AM; Woods CG; Arlett CF
Br J Cancer; 1999 Mar; 79(7-8):1304-7. PubMed ID: 10098776
[TBL] [Abstract][Full Text] [Related]
8. Cancer risks and mortality in heterozygous ATM mutation carriers.
Thompson D; Duedal S; Kirner J; McGuffog L; Last J; Reiman A; Byrd P; Taylor M; Easton DF
J Natl Cancer Inst; 2005 Jun; 97(11):813-22. PubMed ID: 15928302
[TBL] [Abstract][Full Text] [Related]
9. [Ataxia telangiectasia: what impact in clinical oncology?].
Stoppa-Lyonnet D; Aurias A
Bull Cancer; 1992; 79(7):645-50. PubMed ID: 1467590
[TBL] [Abstract][Full Text] [Related]
10. Malignant neoplasms in the families of patients with ataxia-telangiectasia.
Swift M; Sholman L; Perry M; Chase C
Cancer Res; 1976 Jan; 36(1):209-15. PubMed ID: 1248000
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk in heterozygotes for ataxia-telangiectasia.
Geoffroy-Perez B; Janin N; Ossian K; Laugé A; Croquette MF; Griscelli C; Debré M; Bressac-de-Paillerets B; Aurias A; Stoppa-Lyonnet D; Andrieu N
Int J Cancer; 2001 Jul; 93(2):288-93. PubMed ID: 11410879
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.
Janin N; Andrieu N; Ossian K; Laugé A; Croquette MF; Griscelli C; Debré M; Bressac-de-Paillerets B; Aurias A; Stoppa-Lyonnet D
Br J Cancer; 1999 Jun; 80(7):1042-5. PubMed ID: 10362113
[TBL] [Abstract][Full Text] [Related]
13. Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families.
Renault AL; Mebirouk N; Cavaciuti E; Le Gal D; Lecarpentier J; d'Enghien CD; Laugé A; Dondon MG; Labbé M; Lesca G; Leroux D; Gladieff L; Adenis C; Faivre L; Gilbert-Dussardier B; Lortholary A; Fricker JP; Dahan K; Bay JO; Longy M; Buecher B; Janin N; Zattara H; Berthet P; Combès A; Coupier I; ; Hall J; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Carcinogenesis; 2017 Oct; 38(10):994-1003. PubMed ID: 28981872
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer incidence and the effect of cigarette smoking in heterozygous carriers of mutations in the ataxia-telangiectasia gene.
Swift M; Lukin JL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3188-92. PubMed ID: 18990761
[TBL] [Abstract][Full Text] [Related]
15. Cancer risks in A-T heterozygotes.
Easton DF
Int J Radiat Biol; 1994 Dec; 66(6 Suppl):S177-82. PubMed ID: 7836845
[TBL] [Abstract][Full Text] [Related]
16. Public health burden of cancer in ataxia-telangiectasia heterozygotes.
Swift M
J Natl Cancer Inst; 2001 Jan; 93(2):84-5. PubMed ID: 11208872
[No Abstract] [Full Text] [Related]
17. Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.
van Os NJ; Roeleveld N; Weemaes CM; Jongmans MC; Janssens GO; Taylor AM; Hoogerbrugge N; Willemsen MA
Clin Genet; 2016 Aug; 90(2):105-17. PubMed ID: 26662178
[TBL] [Abstract][Full Text] [Related]
18. Cancer predisposition of ataxia-telangiectasia heterozygotes.
Swift M; Chase CL; Morrell D
Cancer Genet Cytogenet; 1990 May; 46(1):21-7. PubMed ID: 2184933
[TBL] [Abstract][Full Text] [Related]
19. "AT risk" for breast cancer.
Bebb G; Glickman B; Gelmon K; Gatti R
Lancet; 1997 Jun; 349(9068):1784-5. PubMed ID: 9269208
[No Abstract] [Full Text] [Related]
20. Breast cancer and radiotherapy in ataxia-telangiectasia heterozygote.
Ramsay J; Birrell G; Lavin M
Lancet; 1996 Jun; 347(9015):1627. PubMed ID: 8667896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
